169 related articles for article (PubMed ID: 37620622)
21. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
22. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
23. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.
Rawangkan A; Wongsirisin P; Namiki K; Iida K; Kobayashi Y; Shimizu Y; Fujiki H; Suganuma M
Molecules; 2018 Aug; 23(8):. PubMed ID: 30126206
[TBL] [Abstract][Full Text] [Related]
24. PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway.
Zhao S; Gao J; Li J; Wang S; Yuan C; Liu Q
Inflammation; 2021 Oct; 44(5):1969-1981. PubMed ID: 34014492
[TBL] [Abstract][Full Text] [Related]
25. Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.
von Knethen A; Schäfer A; Kuchler L; Knape T; Christen U; Hintermann E; Fißlthaler B; Schröder K; Brandes RP; Genz B; Abshagen K; Pützer BM; Sha LK; Weigert A; Syed SN; Schulz M; Shah AM; Ernst A; Putyrski M; Finkelmeier F; Pesic M; Greten F; Hogardt M; Kempf VAJ; Gunne S; Parnham MJ; Brüne B
Theranostics; 2019; 9(7):2003-2016. PubMed ID: 31037153
[TBL] [Abstract][Full Text] [Related]
26. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
Cheng CC; Lin HC; Tsai KJ; Chiang YW; Lim KH; Chen CG; Su YW; Peng CL; Ho AS; Huang L; Chang YC; Lin HC; Chang J; Chang YF
Mol Carcinog; 2018 Nov; 57(11):1588-1598. PubMed ID: 30035369
[TBL] [Abstract][Full Text] [Related]
28. Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis.
Wang F; Huang X; Chung CS; Chen Y; Hutchins NA; Ayala A
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G237-45. PubMed ID: 27288425
[TBL] [Abstract][Full Text] [Related]
29. The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats.
Koga H; Hagiwara S; Inomata M; Kono Y; Oyama Y; Kai S; Nishida T; Noguchi T
Inflammation; 2012 Apr; 35(2):545-53. PubMed ID: 21603971
[TBL] [Abstract][Full Text] [Related]
30. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells.
Coombs MRP; Harrison ME; Hoskin DW
Cancer Lett; 2016 Oct; 380(2):424-433. PubMed ID: 27378243
[TBL] [Abstract][Full Text] [Related]
31. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
32. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.
Ahmad A; Vieira JC; de Mello AH; de Lima TM; Ariga SK; Barbeiro DF; Barbeiro HV; Szczesny B; Törö G; Druzhyna N; Randi EB; Marcatti M; Toliver-Kinsky T; Kiss A; Liaudet L; Salomao R; Soriano FG; Szabo C
Pharmacol Res; 2019 Jul; 145():104263. PubMed ID: 31071432
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
[TBL] [Abstract][Full Text] [Related]
34. IFIH1/IRF1/STAT1 promotes sepsis associated inflammatory lung injury via activating macrophage M1 polarization.
Wang A; Kang X; Wang J; Zhang S
Int Immunopharmacol; 2023 Jan; 114():109478. PubMed ID: 36462334
[TBL] [Abstract][Full Text] [Related]
35. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
[TBL] [Abstract][Full Text] [Related]
36. Caffeic acid modulates activation of neutrophils and attenuates sepsis-induced organ injury by inhibiting 5-LOX/LTB4 pathway.
Yu CM; Wang Y; Ren SC; Liu ZL; Zhu CL; Liu Q; Li HR; Sun CY; Sun XY; Xie J; Wang JF; Deng XM
Int Immunopharmacol; 2023 Dec; 125(Pt A):111143. PubMed ID: 37913569
[TBL] [Abstract][Full Text] [Related]
37. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
[TBL] [Abstract][Full Text] [Related]
38. Oleic acid and oleoylethanolamide decrease interferon-γ-induced expression of PD-L1 and induce apoptosis in human lung carcinoma cells.
Yamagata K; Uzu E; Yoshigai Y; Kato C; Tagami M
Eur J Pharmacol; 2021 Jul; 903():174116. PubMed ID: 33957086
[TBL] [Abstract][Full Text] [Related]
39. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway.
Nakamori Y; Park EJ; Shimaoka M
Front Immunol; 2020; 11():624279. PubMed ID: 33679715
[TBL] [Abstract][Full Text] [Related]
40. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
Xu L; Zhang Y; Tian K; Chen X; Zhang R; Mu X; Wu Y; Wang D; Wang S; Liu F; Wang T; Zhang J; Liu S; Zhang Y; Tu C; Liu H
J Exp Clin Cancer Res; 2018 Oct; 37(1):261. PubMed ID: 30373602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
